Comparative Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-Like Peptide 1 Receptor Agonists, and Nonsteroidal Mineralocorticoid Receptor Antagonists in Chronic Kidney Disease and Type 2 Diabetes: A Systematic Review and Network Meta-Analysis.
Nguyen Bao NgocLe NguyenShweta MitalShawn BugdenHai Van NguyenPublished in: Diabetes, obesity & metabolism (2023)
SGLT-2i were associated with better cardiorenal protection than GLP-1RA and nsMRA in patients with CKD and T2D. This article is protected by copyright. All rights reserved.